A detailed history of State Of Alaska, Department Of Revenue transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 11,735 shares of NBIX stock, worth $1.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,735
Previous 10,940 7.27%
Holding current value
$1.4 Million
Previous $1.51 Million 10.23%
% of portfolio
0.01%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$114.58 - $153.15 $91,091 - $121,754
795 Added 7.27%
11,735 $1.35 Million
Q2 2024

Aug 05, 2024

BUY
$130.86 - $143.19 $18,974 - $20,762
145 Added 1.34%
10,940 $1.51 Million
Q1 2024

Apr 19, 2024

BUY
$130.4 - $143.74 $24,124 - $26,591
185 Added 1.74%
10,795 $1.49 Million
Q4 2023

Jan 19, 2024

SELL
$106.07 - $132.76 $105,539 - $132,096
-995 Reduced 8.57%
10,610 $1.4 Million
Q3 2023

Oct 16, 2023

SELL
$94.02 - $117.1 $46,069 - $57,379
-490 Reduced 4.05%
11,605 $1.31 Million
Q2 2023

Jul 24, 2023

SELL
$89.53 - $104.87 $108,689 - $127,312
-1,214 Reduced 9.12%
12,095 $1.14 Million
Q1 2023

Apr 17, 2023

SELL
$94.11 - $123.02 $13,834 - $18,083
-147 Reduced 1.09%
13,309 $1.35 Million
Q4 2022

Jan 11, 2023

BUY
$106.72 - $127.06 $19,743 - $23,506
185 Added 1.39%
13,456 $1.61 Million
Q3 2022

Oct 20, 2022

SELL
$92.03 - $107.81 $42,333 - $49,592
-460 Reduced 3.35%
13,271 $1.41 Million
Q2 2022

Jul 08, 2022

BUY
$75.79 - $100.07 $29,179 - $38,526
385 Added 2.88%
13,731 $1.34 Million
Q1 2022

Apr 14, 2022

SELL
$72.45 - $94.81 $27,893 - $36,501
-385 Reduced 2.8%
13,346 $1.25 Million
Q4 2021

Jan 12, 2022

SELL
$79.65 - $106.22 $63,321 - $84,444
-795 Reduced 5.47%
13,731 $1.17 Million
Q3 2021

Oct 07, 2021

SELL
$86.18 - $99.03 $13,530 - $15,547
-157 Reduced 1.07%
14,526 $1.39 Million
Q2 2021

Jul 12, 2021

SELL
$89.43 - $102.27 $4.07 Million - $4.66 Million
-45,517 Reduced 75.61%
14,683 $1.43 Million
Q1 2021

Apr 09, 2021

BUY
$87.57 - $119.4 $827,011 - $1.13 Million
9,444 Added 18.61%
60,200 $5.85 Million
Q4 2020

Jan 08, 2021

SELL
$86.91 - $108.33 $711,271 - $886,572
-8,184 Reduced 13.89%
50,756 $4.86 Million
Q3 2020

Oct 05, 2020

BUY
$96.16 - $135.15 $37,021 - $52,032
385 Added 0.66%
58,940 $5.67 Million
Q2 2020

Jul 06, 2020

BUY
$85.09 - $130.36 $4.98 Million - $7.63 Million
58,555 New
58,555 $7.14 Million
Q3 2019

Oct 02, 2019

SELL
$83.82 - $101.5 $882,792 - $1.07 Million
-10,532 Closed
0 $0
Q2 2019

Jul 23, 2019

BUY
$72.24 - $91.27 $2,167 - $2,738
30 Added 0.29%
10,532 $889,000
Q1 2019

Apr 09, 2019

SELL
$69.31 - $91.53 $34,169 - $45,124
-493 Reduced 4.48%
10,502 $925,000
Q4 2018

Jan 10, 2019

BUY
$68.32 - $124.36 $5,465 - $9,948
80 Added 0.73%
10,995 $785,000
Q3 2018

Oct 09, 2018

BUY
$98.88 - $125.85 $11,371 - $14,472
115 Added 1.06%
10,915 $1.34 Million
Q2 2018

Jul 10, 2018

BUY
$75.3 - $105.99 $198,039 - $278,753
2,630 Added 32.19%
10,800 $1.06 Million
Q1 2018

Apr 19, 2018

BUY
$75.88 - $92.43 $134,307 - $163,601
1,770 Added 27.66%
8,170 $677,000
Q4 2017

Jan 19, 2018

BUY
$58.53 - $77.59 $374,592 - $496,576
6,400
6,400 $496,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.4B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.